Graf Akcie CYTK (Cytokinetics Inc). Diskuze k akciím CYTK. Aktuální informace CYTK.

Základní informace o společnosti Cytokinetics Inc (Akcie CYTK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.65B
Hodnota podniku (EV) 2.53B
Tržby 57.801M
EBITDA -124.54
Zisk -155.76
Růst v tržbách Q/Q -20.87 %
Růst v tržbách Y/Y 209.34 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.59
EV/Sales 43.84
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 45.78
P/FCF N/A
Price/Book 23.34
Účetní hodnota na akcii 1.58
Hotovost na akcii 6.47
FCF vůči ceně -0.64 %
Počet zaměstnanců 184
Tržba na zaměstnance 314.136k
Profit margin -228.00 %
Operating margin -219.08 %
Gross margin 100.00 %
EBIT margin -241.71 %
EBITDA margin -215.47 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 26.47 %
EPS - Očekávaný růst příští rok 1,440.00 %
Return on assets -28.99 %
Return on equity -179.39 %
ROIC -27.03 %
ROCE -27.80 %
Dluhy/Equity 3.71
Čistý dluh/EBITDA 7.30
Current ratio 5.90
Quick Ratio 5.90
Volatilita 4.82
Beta 1.01
RSI 56.79
Cílová cena analytiků 24
Známka akcie (dle analytiků) 1.33
Insider ownership 4.76 %
Institutional ownership 93.86 %
Počet akcií 83.513M
Procento shortovaných akcií 16.08 %
Short ratio 3.13 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie CYTK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$26.868$31.501$13.368$106.407$28.658$46.94
Cost Of Goods Sold------
Gross Profit$26.868$31.501$13.368$106.407$28.658$46.94
Research And Development Expenses$86.125$89.135$90.296$59.897$46.398$44.426
SG&A Expenses$39.61$31.282$36.468$27.823$19.667$17.268
Other Operating Income Or Expenses------
Operating Expenses$125.735$120.417$126.764$87.72$66.065$61.694
Operating Income$-98.867$-88.916$-113.396$18.687$-37.407$-14.754
Total Non-Operating Income/Expense$-22.825$-17.373$-14.394$-2.234$-0.094$0.108
Pre-Tax Income$-121.692$-106.289$-127.79$16.453$-37.501$-14.646
Income Taxes------
Income After Taxes$-121.692$-106.289$-127.79$16.453$-37.501$-14.646
Other Income------
Income From Continuous Operations$-121.692$-106.289$-127.79$16.453$-37.501$-14.646
Income From Discontinued Operations------
Net Income$-121.692$-106.289$-127.79$16.453$-37.501$-14.646
EBITDA$-97.574$-87.677$-111.476$19.428$-36.818$-14.264
EBIT$-98.867$-88.916$-113.396$18.687$-37.407$-14.754
Basic Shares Outstanding585449403936
Shares Outstanding585449433936
Basic EPS$-2.11$-1.95$-2.59$0.41$-0.97$-0.41
EPS - Earnings Per Share$-2.11$-1.95$-2.59$0.39$-0.97$-0.41
# 2020 2019 2018 2017 2016 2015
Current Ratio8.98259.35728.45444.76983.57385.497
Long-term Debt / Capital1.09240.60550.22440.22490.1759-
Debt/Equity Ratio-11.81831.63540.28930.31670.2134-
Gross Margin100100100100100100
Operating Margin-367.9731-282.2641-848.264517.5618-130.529-31.4316
EBIT Margin-367.9731-282.2641-848.264517.5618-130.529-31.4316
EBITDA Margin-363.1606-278.3308-833.901918.2582-128.4737-30.3877
Pre-Tax Profit Margin-452.9254-337.4147-955.939615.4623-130.857-31.2015
Net Profit Margin-452.9254-337.4147-955.939615.4623-130.857-31.2015
Asset Turnover0.09270.14920.04530.62540.24870.353
Inventory Turnover Ratio------
Receiveable Turnover5.20414.119712.02164433.6252388.1671.0063
Days Sales In Receivables70.13925.850530.36210.08230.1528362.7139
ROE - Return On Equity1112.667-409.8439-116.339817.4362-54.6742-15.9085
Return On Tangible Equity1112.662-409.8444-116.339817.4362-54.6742-15.9085
ROA - Return On Assets-41.9897-50.3315-43.34669.6702-32.5425-11.0147
ROI - Return On Investment-102.8499-161.6809-90.235113.5146-45.0576-15.9085
Book Value Per Share-0.18480.4742.03562.32151.73292.3814
Operating Cash Flow Per Share0.2810.1998-2.92860.74311.3816-0.9728
Free Cash Flow Per Share0.25160.242-2.95020.72081.3981-0.9843